Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
86.3M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
20.7M
-
Shares change
-
+1.53M
-
Total reported value, excl. options
-
$328M
-
Value change
-
+$22.8M
-
Number of buys
-
29
-
Number of sells
-
-15
-
Price
-
$15.86
Significant Holders of Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC) as of Q4 2021
57 filings reported holding IPSC - Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2021.
Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.7M shares
of 86.3M outstanding shares and own 23.97% of the company stock.
Largest 10 shareholders include FMR LLC (8.2M shares), Casdin Capital, LLC (3.21M shares), FEDERATED HERMES, INC. (1.16M shares), RA CAPITAL MANAGEMENT, L.P. (914K shares), Avidity Partners Management LP (852K shares), BlackRock Inc. (827K shares), Octagon Capital Advisors LP (703K shares), MARSHALL WACE, LLP (701K shares), HHLR ADVISORS, LTD. (614K shares), and Logos Global Management LP (614K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.